Dilated cardiomyopathy: genetic determinants and mechanisms

EM McNally, L Mestroni - Circulation research, 2017 - Am Heart Assoc
Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of
the large number of genes and alleles attributed to DCM, comprehensive genetic testing …

[HTML][HTML] Coenzyme Q10: Clinical applications in cardiovascular diseases

A Martelli, L Testai, A Colletti, AFG Cicero - Antioxidants, 2020 - mdpi.com
Coenzyme Q 10 (CoQ 10) is a ubiquitous factor present in cell membranes and
mitochondria, both in its reduced (ubiquinol) and oxidized (ubiquinone) forms. Its levels are …

[HTML][HTML] Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome

Y Zhao, C Wang, X Hong, J Miao, Y Liao, FF Hou… - Kidney international, 2019 - Elsevier
In type 2 cardiorenal syndrome, chronic heart failure is thought to cause or promote chronic
kidney disease; however, the underlying mechanisms remain poorly understood. We …

[HTML][HTML] Unravelling fibromyalgia—steps toward individualized management

W Häuser, S Perrot, DJ Clauw, MA Fitzcharles - The Journal of Pain, 2018 - Elsevier
The heterogeneity of the clinical presentation and the pathophysiologic mechanisms
associated with fibromyalgia (FM), and the modest results on average for any therapy, call …

High‐protein vs. standard‐protein diets in overweight and obese patients with heart failure and diabetes mellitus: findings of the Pro‐HEART trial

LS Evangelista, MM Jose, H Sallam, H Serag… - ESC Heart …, 2021 - Wiley Online Library
Aims The intermediate‐term effects of dietary protein on cardiometabolic risk factors in
overweight and obese patients with heart failure and diabetes mellitus are unknown. We …

Effectiveness of the pharmacist-involved multidisciplinary management of heart failure to improve hospitalizations and mortality rates in 4630 patients: a systematic …

DR Parajuli, C Kourbelis, J Franzon, P Newman… - Journal of Cardiac …, 2019 - Elsevier
Background There is evidence that heart failure (HF) patients who receive pharmacist care
have better clinical outcomes. Methods and Results English-language peer-reviewed …

[HTML][HTML] Mitochondrial function, dynamics and quality control in the pathophysiology of HFpEF

A Del Campo, G Perez, PF Castro, V Parra… - … et Biophysica Acta (BBA …, 2021 - Elsevier
Heart failure (HF) is one of the leading causes of hospitalization for the adult population and
a major cause of mortality worldwide. The HF syndrome is characterized by the heart's …

[HTML][HTML] Heart failure with preserved ejection fraction: a systemic disease linked to multiple comorbidities, targeting new therapeutic options

Y Juillière, C Venner, L Filippetti, B Popovic… - Archives of …, 2018 - Elsevier
Heart failure is a pathology associated with severe morbidity and mortality. In this large field,
heart failure with preserved ejection fraction (HFpEF) appears to be an increasing global …

[HTML][HTML] Maternal and fetal outcomes in pregnancy complicated with Eisenmenger syndrome

S Katsurahgi, C Kamiya, K Yamanaka, R Neki… - Taiwanese Journal of …, 2019 - Elsevier
Objective The goal of the study was to clarify the risk factors for pregnancy complicated with
Eisenmenger syndrome (ES). Materials and methods A retrospective study was performed in …

Role of the pharmacist for improving self-care and outcomes in heart failure

DR Parajuli, J Franzon, RA McKinnon, S Shakib… - Current heart failure …, 2017 - Springer
Abstract Purpose of Review This review highlights the current and emerging approaches for
the role of the pharmacist for improving self-care and outcomes in heart failure management …